Detalhe da pesquisa
1.
MEN1 mutations mediate clinical resistance to menin inhibition.
Nature
; 615(7954): 913-919, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922589
2.
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation.
Blood
; 139(25): 3630-3646, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421216
3.
15 years after a giant leap for cancer genomics.
Nature
; 623(7989): 920-921, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012374
4.
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
Blood
; 137(10): 1377-1391, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871587
5.
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Am J Hematol
; 98(1): 79-89, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251406
6.
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches.
Mol Cell
; 60(4): 561-70, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26590715
7.
[SENP1 induced protein deSUMO modification increased the chemotherapy sensitivity of endometrial cancer side population cells].
Zhonghua Zhong Liu Za Zhi
; 44(12): 1362-1368, 2022 Dec 23.
Artigo
em Chinês
| MEDLINE | ID: mdl-36575788
8.
LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML.
Blood
; 131(15): 1730-1742, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29453291
9.
Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia.
Haematologica
; 104(7): 1378-1387, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523054
10.
[Magnetic resonance imaging findings of hypovascular clear cell renal cell carcinoma].
Zhonghua Yi Xue Za Zhi
; 99(21): 1660-1663, 2019 Jun 04.
Artigo
em Chinês
| MEDLINE | ID: mdl-31189267
11.
[DeSUMOylation of protein kinase B1 inhibits cell proliferation and metastasis of hepatocellular carcinoma].
Zhonghua Zhong Liu Za Zhi
; 39(11): 814-820, 2017 Nov 23.
Artigo
em Chinês
| MEDLINE | ID: mdl-29151287
12.
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy.
Am J Hematol
; 96(5): E171-E175, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650111
13.
Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer.
Radiat Oncol
; 19(1): 23, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355495
14.
Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study.
Eur Urol
; 85(3): 217-226, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37891072
15.
CRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype Specific Vulnerability in IDH2- and TET2-Mutant Cells.
Cancer Discov
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819218
16.
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.
Blood Adv
; 8(2): 429-440, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871309
17.
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.
Cancer Discov
; 14(5): 737-751, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38230747
18.
Metabolic and magnetic resonance imaging: complementary modalities for the preoperative assessment of lateral pelvic lymph nodes in rectal cancer.
ANZ J Surg
; 93(1-2): 196-205, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074654
19.
Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia.
Sci Adv
; 9(38): eadg0488, 2023 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37729414
20.
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance.
Cancer Discov
; 13(1): 170-193, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222845